Clinical trials
Hematologic Neoplasms trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Affiliated People's Hospital of Ningbo University | 2 |
| Children's Cancer Group, China | 1 |
| Children's Hospital of Fudan University | 1 |
| Chinese PLA General Hospital | 1 |
| Nanjing University of Traditional Chinese Medicine | 1 |
| RenJi Hospital | 1 |
| Ruijin Hospital | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| Xijing Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 12 |
| Body Weight | 1 |
| Hematologic Diseases | 1 |
| Immunologic Deficiency Syndromes | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Prolymphocytic | 1 |
| Lymphoma | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Mantle-Cell | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.